ClinicalTrials.Veeva

Menu
F

Floridian Clinical Research | Miami Lakes, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Lenacapavir
Islatravir
VIR-2218
Doravirine
Brenipatide
Semaglutide
RTA 901
Efinopegdutide
MK-6024
Tirzepatide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

32 of 70 total trials

A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)

The purpose of this study is to learn what happens to nemtabrutinib in a person's body when given to participants with severe kidney disease and to h...

Enrolling
Severe Renal Impairment
Healthy
Drug: Nemtabrutinib

The main purpose of the SYNERGY-OUTCOMES study is to find out whether retatrutide and tirzepatide can prevent major adverse liver outcomes (MALO) in...

Enrolling
Metabolic Dysfunction-Associated Steatotic Liver Disease
Drug: Tirzepatide
Drug: Placebo

A 52-Week, Multi-center, Open-label, Active Treatment Extension Study to Evaluate Safety and Tolerability of Once Daily, Oral Administration of Resme...

Active, not recruiting
Non-Alcoholic Fatty Liver Disease
Drug: Resmetirom

The primary objective of this trial is to evaluate the dose-dependent and comparative effects of ECC4703 (low and high dose), ECC0509 (low and high d...

Enrolling
Metabolic Dysfunction-associated Steatohepatitis
Drug: Placebo
Drug: ECC4703

The goal of this clinical study is to learn if giving repeated annual doses of MK-1406 (CD388) is safe and how the body reacts to it in healthy adult...

Active, not recruiting
Healthy Participants
Combination Product: MK-1406 Injection

The purpose of this study is to assess the efficacy and safety of brenipatide when administered with standard of care (SoC), compared with placebo pl...

Enrolling
Bipolar Disorder
Drug: Brenipatide
Drug: Placebo

This study evaluates the safety and efficacy of brenipatide when administered with standard of care (SoC) compared to placebo plus SoC in delaying th...

Enrolling
Depressive Disorder, Major
Drug: Placebo
Drug: Brenipatide

The purpose of this study is to evaluate the safety and tolerability of DOR/ISL in adult participants with HIV-1 who had been previously treated with...

Active, not recruiting
HIV Infection
Drug: DOR/ISL

The purpose of the study is to assess the amount of Eloralintide (LY3841136) that reaches the bloodstream and the time it takes for the body to get r...

Active, not recruiting
Renal Impairment
Renal Insufficiency Chronic
Drug: LY3841136

The study will have two parts: Part A and Part B. In Part A, the goal of the study is to compare the effectiveness of switching to the study drugs GS...

Enrolling
HIV-1-infection
Drug: Lenacapavir Injection
Drug: GS-3242 Injection

The purpose of this study is to evaluate how well LY4213663 is tolerated and what side effects may occur in healthy participants and participants wit...

Enrolling
Rheumatoid Arthritis (RA)
Drug: LY4213663
Drug: Placebo

The purpose of this study is to evaluate how well nipocalimab works as compared to placebo in participants with moderate to severe Systemic lupus ery...

Enrolling
Lupus Erythematosus, Systemic
Drug: Nipocalimab
Drug: Standard of care treatment

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide

This study will be conducted to assess the safety and pharmacokinetics of INCB123667 when administered orally to adult participants with severe renal...

Enrolling
Renal Impairment
Drug: INCB123667

This study will be a placebo-controlled, double-blind, randomized, Phase 3 study to evaluate the efficacy, safety, and tolerability of obicetrapib 10...

Active, not recruiting
Type 2 Diabetes (T2DM)
Metabolic Syndrome (MetS)
Drug: Obicetrapib 10 mg
Other: Placebo

Approximately one billion cases of seasonal influenza occur annually. Of these, 3 to 5 million illnesses are severe and responsible for up to 650,000...

Active, not recruiting
Influenza
Combination Product: MK-1406
Combination Product: Placebo

This study is being done to learn more about an investigational medicine called PF-08653944. The goal is to understand how the body handles the medic...

Enrolling
Healthy
Drug: PF-08653944

The purpose of the study is to look at how the body processes a study medicine called vepdegestrant in participants with loss of liver function relat...

Enrolling
Healthy Participants
Drug: vepdegestrant

The purpose of this study to understand how the study medicine atirmociclib behaves in the body and how safe it is for people with different levels o...

Enrolling
Hepatic Impairment
Healthy, Hepatic Insufficiency
Drug: Atirmociclib

The main objective of this trial will be to determine whether maridebart cafraglutide is superior to placebo on reduction in liver fat content and bo...

Enrolling
Overweight or Obesity and Elevated Liver Fat
Drug: Placebo
Drug: Maridebart cafraglutide

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Lilly logo
Gilead Sciences logo
Amgen logo
Moderna logo
Pfizer logo
C
Boehringer Ingelheim logo
Janssen (J&J Innovative Medicine) logo
Novo Nordisk logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems